303 related articles for article (PubMed ID: 2123366)
1. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
Versiani M; Nardi AE; Figueira IL; Stabl M
Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
3. RIMA--a new concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
[TBL] [Abstract][Full Text] [Related]
4. RIMA: a safe concept in the treatment of depression with moclobemide.
Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
[TBL] [Abstract][Full Text] [Related]
5. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Ucha Udabe R; Márquez CA; Traballi CA; Portes N
Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
9. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
10. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
Stabl M; Biziére K; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide: therapeutic use and clinical studies.
Bonnet U
CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide--placebo-controlled trials.
Silverstone T
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
Bizière K; Berger M
Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
[TBL] [Abstract][Full Text] [Related]
14. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
Norman TR; Burrows GD
Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
[TBL] [Abstract][Full Text] [Related]
15. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
Tiller JW; Maguire KP; Davies BM
Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide. An update of its pharmacological properties and therapeutic use.
Fulton B; Benfield P
Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
[TBL] [Abstract][Full Text] [Related]
17. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].
Barrelet L; Blajev B; Bolzani L; de Saussure C; Kasas A; Van H; Gachoud JP
Schweiz Rundsch Med Prax; 1991 May; 80(19):524-8. PubMed ID: 1904620
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Roth M; Guelfi JD
Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
[TBL] [Abstract][Full Text] [Related]
20. The role of moclobemide in endogenous depression: a survey of recent data.
Woggon B
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):137-9. PubMed ID: 8468434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]